Effect of the Bile Acid Sequestrant Colesevelam on Health Related Quality of Life in Crohn's Disease

被引：0
|
作者：
Umapathy, Chandraprakash
Rivers, Claudia M. Ramos
Regueiro, Miguel
Baidoo, Leonard
Barrie, Arthur
Schwartz, Marc
Swoger, Jason M.
Dunn, Michael A.
Weyant, Katherine A.
Watson, Andrew R.
Binion, David G.
机构：
来源：
GASTROENTEROLOGY | 2013年 / 144卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S443 / S443
页数：1
相关论文
共 50 条
  • [31] Colesevelam hydrochloride (Cholestagel) - A new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects
    Davidson, MH
    Dillon, MA
    Gordon, B
    Jones, P
    Samuels, J
    Weiss, S
    Isaacsohn, J
    Toth, P
    Burke, SK
    ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (16) : 1893 - 1900
  • [32] Effect of Intestinal Resection on Quality of Life in Crohn's Disease
    Wright, Emily K.
    Kamm, Michael A.
    De Cruz, Peter
    Hamilton, Amy L.
    Ritchie, Kathryn J.
    Krejany, Efrosinia O.
    Gorelik, Alexandra
    Liew, Danny
    Prideaux, Lani
    Lawrance, Ian C.
    Andrews, Jane M.
    Bampton, Peter A.
    Sparrow, Miles P.
    Florin, Timothy H.
    Gibson, Peter R.
    Debinski, Henry
    Gearry, Richard B.
    Macrae, Finlay A.
    Leong, Rupert W.
    Kronborg, Ian
    Radford-Smith, Graeme
    Selby, Warwick
    Johnston, Michael J.
    Woods, Rodney
    Elliott, P. Ross
    Bell, Sally J.
    Brown, Steven J.
    Connell, William R.
    Desmond, Paul V.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (06): : 452 - 462
  • [33] Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion (vol 18, pg 571, 2017)
    Hansen, M.
    Scheltema, M. J.
    Sonne, D. P.
    Hansen, J. S.
    Sperling, M.
    Rehfeld, J. F.
    Holst, J. J.
    Vilsboll, T.
    Knop, F. K.
    DIABETES OBESITY & METABOLISM, 2018, 20 (03): : 759 - 759
  • [34] Predictors of health-related quality of life in patients with Crohn's disease receiving biological therapy
    Lundquist, Lasse R.
    Rasmussen, Bjorn
    Waldorff, Frans Boch
    Wehberg, Sonja
    Kjeldsen, Jens
    Haastrup, Peter
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2021, 56 (12) : 1434 - 1441
  • [35] The Effects of Ustekinumab on Health-related Quality of Life in Patients With Moderate to Severe Crohn's Disease
    Sands, Bruce E.
    Han, Chenglong
    Gasink, Christopher
    Jacobstein, Douglas
    Szapary, Philippe
    Gao, Long-Long
    Lang, Yinghua
    Targan, Stephan
    Sandborn, William J.
    Feagan, Brian G.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (08): : 883 - 895
  • [36] Health-related quality of life in Crohn's disease: A prospective longitudinal study in 231 patients
    Blondel-Kucharski, F
    Chircop, C
    Marquis, P
    Cortot, A
    Baron, F
    Gendre, JP
    Colombel, JF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (10): : 2915 - 2920
  • [37] Relevance of the phenotypic characteristics of Crohn's disease in patient perception of health-related quality of life
    Casellas, F
    Vivancos, JL
    Sampedro, M
    Malagelada, JR
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (12): : 2737 - 2742
  • [38] Health-related quality of life in Crohn's disease: Whose preferences should we use?
    Myers, RP
    Gregor, JC
    Panaccione, R
    McDonald, JW
    Feagan, BG
    GASTROENTEROLOGY, 2000, 118 (04) : A214 - A214
  • [39] Maintenance treatment with natalizumab improves the health related quality of life (HRQOL) in Crohn's disease patients
    Feagan, Brian
    Colombel, Jean-Frederic
    Enns, Robert
    Hanauer, Stephen
    Lawrance, Ian
    Panaccione, Remo
    Rutgeerts, Paul
    Schreiber, Stefan
    Targan, Stephan
    Deventer, Sander van
    Sandborn, William
    GASTROENTEROLOGY, 2006, 130 (04) : A485 - A485
  • [40] Different perception of health related quality of life in ulcerative colitis vs Crohn's disease.
    Lopez-Vivancos, J
    Casellas, F
    Badia, X
    Vilaseca, J
    Malagelada, JR
    GASTROENTEROLOGY, 1999, 116 (04) : A765 - A765
12345